Stock comparison
RESMED INC is 3.3x more valuable than GLAUKOS Corp by market capitalization ($29.57 B vs $8.97 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
RMD is larger
RESMED INC is 3.3x more valuable than GLAUKOS Corp by market capitalization ($29.57 B vs $8.97 B).
Market value leader
RMD
RESMED INC is 3.3x more valuable than GLAUKOS Corp by market capitalization ($29.57 B vs $8.97 B).
Revenue leader
RMD
GKOS: $507.44M vs RMD: $5.15B.
Profit leader
RMD
GKOS: -$187.69M vs RMD: $1.40B.
Margin leader
RMD
GKOS: -37.0% vs RMD: 27.2% net margin.
| Metric | GKOS | RMD |
|---|---|---|
| Market cap | $8.97 B | $29.57 B |
| US-listed rank | #1025 | #471 |
| Revenue (latest FY) | $507.44M | $5.15B |
| Net income (latest FY) | -$187.69M | $1.40B |
| Net margin | -37.0% | 27.2% |
| P/E (trailing FY) | - | 21.1x |
| SEC filings | 1,014 | 2,518 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
RESMED INC is 3.3x more valuable than GLAUKOS Corp by market capitalization ($29.57 B vs $8.97 B).
In their latest fiscal years, GLAUKOS Corp reported $507.44M in revenue while RESMED INC reported $5.15B.
Full pages: GLAUKOS Corp and RESMED INC, or browse the full rankings.